Uni-Bio Science Group Limited (HKG:0690)
Hong Kong · Delayed Price · Currency is HKD 0.1150
+0.0010 (0.88%)
At close: Feb 13, 2026
Uni-Bio Science Group Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 589.59 | 552.98 | 484.72 | 440.32 | 353.41 | 208.78 | |
Revenue Growth (YoY) | 15.97% | 14.08% | 10.08% | 24.59% | 69.27% | -0.32% |
Cost of Revenue | 105.03 | 91.91 | 91.9 | 105.43 | 76.4 | 27.68 |
Gross Profit | 484.56 | 461.07 | 392.82 | 334.88 | 277.01 | 181.09 |
Selling, General & Admin | 333.36 | 312.24 | 288.65 | 258.31 | 232.85 | 181.35 |
Research & Development | 45.03 | 52.28 | 35.58 | 35.78 | 50.22 | 40.73 |
Other Operating Expenses | -3.5 | -5.53 | -12.29 | -6.99 | -5.16 | -14.92 |
Operating Expenses | 375.07 | 359.17 | 311.93 | 287.64 | 281.84 | 218.04 |
Operating Income | 109.5 | 101.9 | 80.88 | 47.24 | -4.83 | -36.95 |
Interest Expense | -1.68 | -1.19 | -0.78 | -0.38 | -0.48 | -0.07 |
Interest & Investment Income | 3.35 | 3.35 | 1.35 | 1.3 | 0.47 | 0.5 |
Other Non Operating Income (Expenses) | -12.32 | -12.32 | -4.94 | -2.17 | 2.72 | -10.14 |
EBT Excluding Unusual Items | 98.84 | 91.74 | 76.51 | 45.99 | -2.12 | -46.67 |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.04 | 0.95 |
Gain (Loss) on Sale of Assets | -0.57 | -0.57 | -0.61 | -0.76 | -2.63 | -0.39 |
Asset Writedown | - | - | - | - | 0 | -25.74 |
Legal Settlements | - | - | - | -2.31 | -15.61 | - |
Other Unusual Items | - | - | - | 0.36 | 0.3 | 0.91 |
Pretax Income | 98.28 | 91.17 | 75.9 | 43.29 | -20.01 | -70.94 |
Income Tax Expense | 6.93 | 8.4 | 5.02 | 4.78 | -0.42 | 0.38 |
Net Income | 91.35 | 82.77 | 70.88 | 38.51 | -19.59 | -71.32 |
Net Income to Common | 91.35 | 82.77 | 70.88 | 38.51 | -19.59 | -71.32 |
Net Income Growth | -7.60% | 16.79% | 84.04% | - | - | - |
Shares Outstanding (Basic) | 6,044 | 6,140 | 6,365 | 6,361 | 6,372 | 6,408 |
Shares Outstanding (Diluted) | 6,044 | 6,140 | 6,365 | 6,361 | 6,372 | 6,408 |
Shares Change (YoY) | -3.52% | -3.53% | 0.07% | -0.17% | -0.57% | 2.04% |
EPS (Basic) | 0.02 | 0.01 | 0.01 | 0.01 | -0.00 | -0.01 |
EPS (Diluted) | 0.02 | 0.01 | 0.01 | 0.01 | -0.00 | -0.01 |
EPS Growth | -4.01% | 21.44% | 83.35% | - | - | - |
Free Cash Flow | 32.93 | 28.71 | 39.11 | 20.23 | 3.61 | -18.91 |
Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | -0.00 |
Dividend Per Share | 0.003 | 0.003 | - | - | - | - |
Gross Margin | 82.19% | 83.38% | 81.04% | 76.05% | 78.38% | 86.74% |
Operating Margin | 18.57% | 18.43% | 16.69% | 10.73% | -1.37% | -17.70% |
Profit Margin | 15.49% | 14.97% | 14.62% | 8.75% | -5.54% | -34.16% |
Free Cash Flow Margin | 5.58% | 5.19% | 8.07% | 4.59% | 1.02% | -9.06% |
EBITDA | 122.98 | 114.33 | 92.55 | 59.53 | 10.88 | -18.19 |
EBITDA Margin | 20.86% | 20.68% | 19.09% | 13.52% | 3.08% | -8.71% |
D&A For EBITDA | 13.48 | 12.44 | 11.66 | 12.29 | 15.71 | 18.76 |
EBIT | 109.5 | 101.9 | 80.88 | 47.24 | -4.83 | -36.95 |
EBIT Margin | 18.57% | 18.43% | 16.69% | 10.73% | -1.37% | -17.70% |
Effective Tax Rate | 7.05% | 9.21% | 6.62% | 11.03% | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.